Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
- DOI
- 10.3390/cancers15123242
- Published
- 2023-06-19
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers15123242,
title = {Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study},
author = {Karolina Skubisz and Krzysztof Dąbkowski and Emilia Samborowska and Teresa Starzyńska and Anna Deskur and Filip Ambrozkiewicz and Jakub Karczmarski and Mariusz Radkiewicz and Katarzyna Kusnierz and Beata Kos-Kudła and Tadeusz Sulikowski and Patrycja Cybula and Agnieszka Paziewska},
year = {2023},
journal = {Cancers},
doi = {10.3390/cancers15123242},
url = {https://doi.org/10.3390/cancers15123242}
}RIS
TY - JOUR TI - Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study AU - Karolina Skubisz AU - Krzysztof Dąbkowski AU - Emilia Samborowska AU - Teresa Starzyńska AU - Anna Deskur AU - Filip Ambrozkiewicz AU - Jakub Karczmarski AU - Mariusz Radkiewicz AU - Katarzyna Kusnierz AU - Beata Kos-Kudła AU - Tadeusz Sulikowski AU - Patrycja Cybula AU - Agnieszka Paziewska PY - 2023 JO - Cancers DO - 10.3390/cancers15123242 UR - https://doi.org/10.3390/cancers15123242 ER -
APA
Skubisz, K., Dąbkowski, K., Samborowska, E., Starzyńska, T., Deskur, A., Ambrozkiewicz, F., Karczmarski, J., Radkiewicz, M., Kusnierz, K., Kos-Kudła, B., Sulikowski, T., Cybula, P., & Paziewska, A. (2023). Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers. https://doi.org/10.3390/cancers15123242
Source records
- crossref · retrieved 2026-09-26T19:38:42.813Z